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Introduction
 Human gastrointestinal tract is a specific ecosystem 
inhabited by more than 400 diverse microbial species living 
in perfect natural balance. These are the species that have 
been isolated and defined so far and they are present in the 
concentration higher than 1014 organisms/g (Šušković and 
Kos, 2000). The function of intestinal microbial population 
within gastrointestinal tract is multiple, whereas protecting 
organism is considered to be its most important function 
(Vaughan et al., 2000; Falagas et. al., 2008). During the 70’s 
of the 20th century, scientific researches provided sufficient 
firm evidence that the balance among diverse microbial 
species within intestine population is a precondition for the 
preservation of human health.
 Due to growing pollution of the environment, use of 
chemical food additives, frequent international travels, as 
well as antibiotic treatments and radiotherapy, intestinal 
population can be misbalanced. Regardless of sample, 
the most frequent consequence of such misbalances is 
diarrhea, a disease that nearly 4 billion people suffer 
from per year. 5 % of all people on sick-leave suffer from 
diarrhea. Furthermore, about 4 % of the diarrhea inflicted 
population die because of its consequences (Szajewska and 
Mrukowicz, 2005; Sazawal et al., 2006). In developing 
countries, diarrhea caused by pathogen strains Shigella, 
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Vibriocholera, Salmonella, Campylobacter spp., Escherichia 
coli and rotaviruses are major cause of infants and child 
mortality. However, even in developed countries, such as the 
USA, diarrhea is diagnosed in 21 to 37 million cases per year 
within the population of 16.5 million children (Nomoto, 
2005). Traveller’s diarrhea is found in approximately 12 
million cases, and depending on destination, 5 to 50% 
travellers suffer from it (Cheng and Thielman, 2002; 
McFarland, 2007). Diarrhea often happens during or after 
antibiotic treatment (5-25 %) or X-ray treatment of people 
suffering from cancer (Bergogne-Berezin, 2000). Due to 
the fact that more than a half of world grown-up population 
have insufficient quantity of lactase enzyme, diarrhea can be 
caused by consuming food in which lactose share is almost 50 
g. The figure of the real lactose intolerance of the population 
is not fully accurate when commonly consumed quantity of 
milk of 2.5 dcL (12 g of lactose) is taken into consideration. 
It is considered to be less for a half (Miller et al., 2007).
 Lactic acid bacteria and bifidobacteria are characterized 
by ability to create diverse organic compounds and acids, 
hydrogen peroxide, diacethyl , CO2, bacteriocine which they 
secrete into their habitat where they grow (Tamime et al., 
2006). Either food or digestive tract being considered, these 
microrganisms have mainly inhibitory impact on the growth 
of undesirable microbial population for humans (Rogelj and 
Bogović-Matijašić, 1994; Šušković et al., 1997; Šušković 
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et al., 1998; Samaržija et al., 2001, 2001a). Therefore it is 
no surprise that the data from numerous researches prove 
that, apart from their nutritional value, fermented milks 
have direct and/or indirect health-related value (Lukač 
Havranek and Samaržija, 1996). Fermented milks or 
preparations of lactic acid bacteria and bifidobacteria in the 
shape of capsule are proved to have beneficial effects in the 
prevention or as supplement in treatment of many different 
diseases (gastrointestinal, urogenital infections, tumours) 
(Blom and Mortvedt, 1991; Strnad and Babuš, 1996; 
Ouwehand et al., 1999; Betica-Radić, 2000; Sleator and 
Hill, 2007).
 In the prevention and therapy of diarrhea caused bay 
misbalance within intestinal microbial population, the use of 
probiotic lactic acid bacteria and bifidobacteria in particular 
cases has also turned out to be a good choice. To a greater 
or less extent they are capable of re-establishing natural 
microbial balance in intestines (Bergogne-Berezin, 2000; 
Schrezenmeir and de Verse, 2001; Šušković et al., 
2001).
 The aim of this research is to emphasize the most 
important results obtained in about past ten years of 
probiotic bacteria preventive and therapeutic influence on: 
acute diarrhea in children, traveller’s diarrhea, antibiotic 
associated diarrhea, radiotheraphy and lactose intolerance.
Acute diarrhea in children
 The largest number of cases of acute diarrhea in 
children is a result of infection by rotaviruses. Because 
of that, it is no surprise that researches on the probiotic 
bacteria effect in prevention and therapy of diarrhea is 
connected with rotaviruses to a great extent. Thus a study, 
comprising children from one month to 36 months of age, 
showed that the usage of probiotic lactic acid bacteria and/
or bifidobacteria on daily basis, not depending on whether 
these organisms were part of fermented milks, capsule or 
oral rehydration solution, decreases duration of diarrhea for 
30-40 % (Saavedra, 2000).
 In the group of children who were taking probiotics, 
diarrhea lasted for 1.4 to 2.3 days whereas in the placebo 
group diarrhea lasted for 2.4 to 3.2 days (Isolauri et al., 
1991; Boudra et al., 1996; Shornikova, 1997; Guandalini 
et al., 2000; Weizman et al., 2005). The probiotic strains of 
bacteria Lactobacillus rhamnosus GG, Lactobacillus reuteri, 
Lactobacillus delbruecki subsp. Bulgaricus, Bifidobacterium 
lactis and Strptococcus thermophilus not only have therapeutic 
effect, but also have preventive effect on the manifestation 
of acute diarrhea in children. In the 17-month study, carried 
out in 1992 and 1993, only 7 % of the infants who were fed 
with infant formula enriched with Bifidobacterium bifidum 
and Streptococcus thermophilus bacteria had diarrhea. Tha 
manifestation of acute diarrhea during the same research 
period was 31 % with the babies fed with standard infant 
formula. However, the gravity of diarrhea, measured by its 
duration, frequency and stool quantity, has no significant 
difference among the test groups (Saavedra et al., 1994). 
Conversely, the results of the 2-year study (2000-2002) 
show that probiotic bacteria Bifidobacterium lactis and 
Lactobacillus reuteri in the concentration of 107 cfu/g 
decrease the prevalence of diarrhea in infants as well as 
its duration. However, more beneficial probiotic effect on 
the manifestation and duration of diarrhea was determined 
for Lactobacillus reuteri (Weizman et al., 2005). Shorter 
duration of acute diarrhea up to 48 % was determined by 
Rosenfeldt (2002) in the cases when the children were 
consuming Lactobacillus reuteri DSM 12246 (1010 cfu) along 
with Lactobacillus rhamnosus 19070-2 (1010 cfu/g) on a daily 
basis. Acute diarrhea was considerably eased in hospitalized 
children aged from one month to three years who were given 
Lactobacillus rhamnosus GG (1010 cfu/g) on a daily basis. 
Therefore, diarrhea was registered in 7-10 % of infants, 
whereas in the placebo group it was registered in even 33 % 
of cases (Szajewska et al., 2001; Mastretta et al., 2002).
 After acute diarrhea in children caused by diverse 
infectious agents, the ability to colonize intestines with 
Lactobacillus rhamnosus GG bacterium was confirmed in 
78.6 % (virus infection), in 75 % (bacterial infection) and 
in 85.7 % (unknown etiology) of cases (Szymanski et al., 
2006). Therapeutic concentration (1010 cfu/g) contained 
three different strains of Lactobacillus rhamnosus GG in 
ratio 1:1:1.
Traveller’s diarrhea
 Due to contradictory results it is still not possible 
to talk for sure about the definite efficiency of probiotic 
bacteria usage in prophylaxis of traveller’s diarrhea. The 
researches carried out in the 90’s proved that probiotic 
strains Lactobacillus acidophilus alone or combined with 
Lactobacillus fermentum and Lavtobacillus delbruecki subsp. 
bulgaricus do not have considerable effect on prevention and/
or ease of diarrhea (Kollaritsch et al., 1989; Katelaris et 
al., 1995). These results were confirmed by Briand (2006) 
in a double blind randomised study which has shown that 
Lactobacillus acidophilus (1010 cfu/g) taken two times a day 
before and after travelling  does not  prevent diarrhea. On the 
other hand, lyophilized mixed probiotic culture composed 
of Lactobacillus acidophilus, Lactobacillus delbruecki 
subsp. bulgaricus, Bifidibacterium bifidum, Streptococcus 
thermophilus in the concentration of 3x109 cfu/g, which 
was consumed on the same way by Danish tourists during 
two weeks of journey through Egypt, reduced prevalence of 
diarrhea from 71 % to 43 % (Black et al., 1989). Meta analysis 
of six studies conducted by Sazawal et al. (2006) has shown 
that probiotic strains of bacteria Lactobacillus acidophilus, 
Lactobacillus delbruecki subsp. bulgaricus Lactobacillus 
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rhamnosus GG and Lactobacillus fermentum decreased the 
risk of diarrhea development during journey by 8 %. Besides, 
after carrying out the meta analysis of 12 randomised studies, 
McFarland (2007) allege that the usage of a mixed culture 
containing Lactobacillus acidophilus, Bifidobacterium bifidum 
and Saccharomyces boulardii has safe and highly effective 
influence on traveller’s diarrhea prevention. Effectiveness 
of the preventive influence of Lactobacillus rhamnosus 
GG and Lactobacillus acidophilus was tested on a group of 
American tourists who were travelling to different westward 
civilizations risky countries. Research confirmed significantly 
lower prevalence of traveller’s diarrhea in the group which 
has two days before and after the journey taken Lactobacillus 
rhamnosus GG (2x109 cfu/g) in a form of powder, or added 
to fermented milk. Lower preventive influence was found 
for Lactobacillus acidophilus in comparison to Lactobacillus 
rhamnosus GG (Hilton et al., 1997). The influence of 
taking Lactobacillus rhamnosus GG on diarrhea development 
was examined on 820 Finns travelling to two different 
Turkish regions. Probiotic preventive impact of Lactobacillus 
rhamnosus GG was not significant, but it was observed that 
preventive effect depends on travelling region. Although the 
study was unexplained, it is presumed that ineffectiveness in 
preventive effect of these probiotic strains can be ascribed 
to different microbiological agents and the age of placebo 
groups (Oksanen et al., 1990, McFarland, 2007.).
Antibiotic associated diarrhea
 Very often diarrhea could be a consequence of antibiotic 
therapy such as clindamicin, cephalosporin and penicillin. 
Antibiotics cause diarrhea due to disturbance of intestinal 
microflora natural balance which leads to quick growth of 
Clostridium difficile. Bacteria Clostridium difficile normally 
exists at a low level in the intestine of healthy humans 
(Nomoto, 2005). The reason of diarrhea manifestation 
is increase of its number and also as its ability to produce 
enterotoxins - toxin A and/or cytotoxin - toxin B (Marcos 
and DuPont, 2007). Meta analysis of some clinical studies 
shows that taking probiotic strains such as Saccharomyces 
boulardii, Lactobacillus rhamnosus GG, Lactobacillus 
acidophilus and  Lactobacillus delbruecki subsp. bulgaricus 
during antibiotic therapy, decreases the prevalence of 
diarrhea by 52 % comparing to control group. However, 
there is no significant difference in intensity of preventive 
effect between strains regardless if they were used alone 
or in  some combination (D’Souza et al., 2002; Sazawal 
i sur., 2006). Remarkable influence of probiotic strains in 
prevention of children’s diarrhea as a consequence of taking 
antibiotics was confirmed by Johnston et al. (2006.), and 
Szajewska et al. (2006). Treatments with probiotics could 
decrease the risk of antibiotic associated diarrhea in children 
to 11.9 % compared with a rate of 28.5 % cases in the control 
group (McFarland, 2006.). 
Radiation-induced diarrhea 
 Radiotherapy is a method used very often in a medicine 
for treatment of different types of tumours. Negative 
side of radiation is the fact that nearly 80 % of patients 
have acute symptoms and diarrhea. Radiotherapy induced 
diarrhea could be considerably minimized by consuming 
lyophilized mixed probiotic strains composed of four 
Lactobacillus strains, three Bifidobacterium strains and one 
Streptococcus delbrueckii subsp. thermophilus strain (Delia 
et al., 2007). Adversely, Giralt et al. (2008) through double 
blind randomised clinical study defined that probiotic 
drink containing Lactobacillus casei DN-114 001 in the 
concentration of 108 cfu/g does not reduce the incidence 
of radiation-induced diarrhea. Research was carried out on 
patients who were diagnosed and operated endometrial 
adenocarcinoma (mucous membrane of uterus). However, 
significant effect on stool consistency was confirmed which 
shows that there is still positive effect of probiotic bacteria. 
Similar activity in prevention of radiation-induced diarrhea 
was confirmed for probiotic bacteria Lactobacillus rhamnosus 
GG (Urbancsek et al., 2001). 
Diarrhea caused by lactose intolerance
 Because of the lack of the intestine enzyme 
β-galactosidase (lactase), some people do not have the ability 
to degrade lactose. Non-degraded lactose induces illness 
with symptoms such as convulsion, flatulence, diarrhea 
and nausea. After eating yoghurt or other fermented milks, 
lactose intolerance is considerably lower in the comparison 
to the reaction after eating other kinds of dairy foods. In 
fermented milks the concentration of lactose is much lower 
(30 % average), while probiotic variety of fermented milks 
also contains a microbial β-galactosidase (Fooks et al., 1999). 
Fermented milks casein, calcium-phosphate and lactate 
neutralized gastric acid (acting like a buffer). Therefore the 
microbial β-galactosidase in the active form comes to a small 
intestine and the symptoms of the illness absent (Pochart 
et al., 1989). At 80 % of lactose intolerant people, after 
taking 18 g of lactose by milk, diarrhea and/or flatulence will 
occurre. However, symptoms of the illness failed when the 
same content of lactose was consumed along with yoghurt. 
Activity of β-galactosidase contained in yoghurt is enough 
to digest 50-100 % of consumed lactose in amount of 20 g 
(Miller et al., 2007).
Conclusion
 The preventive and therapeutic effect of probiotic 
bacteria is not the same in different types of diarrhea. The 
main value of proven positive results in prevention and 
therapy of infant’s and children’s acute diarrhea as in diarrhea 
caused by antibiotic therapy is reduction of the treatment 
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cost. These researches are very complex which could cause 
different interpretation of results about effectiveness of 
probiotic bacteria in diarrhea prevention and therapy.
Probiotičke bakterije u prevenciji  
i terapiji dijareje
Sažetak
 Probiotičke bakterije pozitivno djeluju u prevenciji 
i terapiji različitih bolesti. U radu su prikazani rezultati 
istraživanja utjecaja probiotičkih bakterija u prevenciji i 
terapiji dijareje provedenih posljednjih desetak godina. 
Najveći preventivni i terapijski učinak probiotičkih bakterija 
utvrđen je za akutnu dijareju u djece uzrokovanu rotavirusima. 
Značajan, ali nešto manji učinak probiotičkih bakterija 
dokazan je kod dijareje kao posljedice uzimanja antibiotika. 
Pozitivan učinak probiotičkih bakterija u prevenciji putničke 
dijareje i dijareje kao posljedice terapije zračenjem nije 
značajan. Preventivni i terapijski učinak na dijareju neovisan 
je o načinu uzimanja probiotičkih bakterija, fermentiranim 
mlijekom, kapsulom ili oralnom rehidratacijskom otopinom.
 Ključne riječi: dijareja, probiotičke bakterije, prevencija, 
terapija 
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